As you would expect now that Benlysta has been approved as the first Lupus treatment in more than 50 years, some investors are wondering and perhaps hoping that Human Genome Sciences, Inc.…
Jon C. Ogg Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of December 31, 2010. That makes these his new 2011 holdings and there…
These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Started as Neutral at Credit Suisse. AstraZeneca (NYSE: AZN) Cut…
Investors have tried for years to follow the strategy of Warren Buffett, considered by many to be the greatest investor in history. That’s ironic given how little he seems to care about…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of September 30, 2010. This list appears to have many more changes than…
The Federal Reserve will begin monetary easing shortly. (Reuters) Oracle (NASDAQ: ORCL) CEO Larry Ellison claims he can prove wrongdoing by Hewlett- Packard’s (NYSE: HPQ) new chief executive. (Reuters) The International Energy…
GSK agreed to pay $750 million to settle false claims suit over the distribution of some of its drugs. The press statement by the company makes it appear almost as it nothing…
Douglas A. McIntyre There are many research calls this Thursday morning and these are just some of the top analyst upgrades, downgrades, and initiations seen in Wall Street research notes: Altria Group Inc. (NYSE: MO)…
These are some of the top analyst research calls for upgrades, downgrades, and initiations this Wednesday morning on Wall Street: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Cut to Market Perform at BMO. ARM…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of June 30, 2010. Some may have changed slightly since the end of…
All of the freshest reports have the Genzyme Corporation (NASDAQ: GENZ) buyout discussions between Sanofi-Aventis (NYSE: SNY) as being a friendly merger. The first discussions noted by the WSJ were a $67…
WSJ: Nokia (NYSE: NOK) will begin the search for a new CEO. Reuters: BP plc (NYSE: BP) will continue its work on the leaking well and said seepage had nothing to do…
Reuters: BP plc (NYSE: BP) has begun to run an important test on its well cap. Reuters: China’s economy expanded at 11.1% in 1H but closed in Q2. Reuters: GlaxoSmithKline (NYSE: GSK)…
Reuters: The financial reform bill should pass within days. Reuters: Intel (NYSE: INTC) posted stronger than expected earnings. Reuters: Toyota Motor (NYSE: TM) blamed driver error for some problems with recalled cars.…
GlaxoSmithKline (NYSE: GSK), like a number of pharmaceutical companies before it, has run up against the truth about one of its drugs. According to The New York Times, “In the fall of…